Manufacturers Life Insurance Company, The Pacira Bio Sciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 16,922 shares of PCRX stock, worth $408,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,922
Previous 17,380
2.64%
Holding current value
$408,497
Previous $261,000
21.84%
% of portfolio
0.0%
Previous 0.0%
Shares
34 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$193 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$127 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$78.8 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$54.5 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$48.1 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.11B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...